A Murine Model for Studying Hematopoiesis and Immunity in Heart Failure

  • Per Ole Iversen
  • Dag R. Sørensen
Part of the Methods in Molecular Biology™ book series (MIMB, volume 360)


Recent epidemiological research indicates that a coexistent anemia among patients with heart failure might worsen their prognosis. However, whether the reduced synthesis of red blood cells is a contributing factor to the development and progression to overt heart failure, or whether it simply is a mere consequence of a dysfunctional heart, remains to be elucidated. Studies in mice with experimentally induced acute myocardial infarction leading to subsequent development of a postinfarction congestive heart failure have shed some light on this problem. Careful analyses of the number and of the functions of various hematopoietic cells residing in either blood or bone marrow point to a possible inhibitory role of cytokines, such tumor necrosis factor α, on hematopoiesis. The present protocols will hopefully encourage further studies of hematopoiesis and immunity in heart failure by using a combination of animal models with state-of-the-art techniques in molecular biology to define and validate possible targets for therapy.

Key Words

Cytokines heart failure hematopoiesis mouse myocardial infarction 


  1. 1.
    McKee, P. A., Castelli, W. P., McNamara, P. M., and Kannel, W. B. (1971) The natural history of congestive heart failure: the Framingham study. N. Engl. J. Med. 285, 1441–1446.CrossRefPubMedGoogle Scholar
  2. 2.
    Khand, A., Gemmel, I., Clark, A. L., and Cleland, J. G. (2000) Is the prognosis of heart failure improving? J. Am. Coll. Cardiol. 36, 2284–2286.CrossRefPubMedGoogle Scholar
  3. 3.
    Kloner, R. A. and Rezkalla, S. H. (2004) Cardiac protection during acute myocardial infarction: where do we stand in 2004. J. Am. Coll. Cardiol. 44, 276–286.CrossRefPubMedGoogle Scholar
  4. 4.
    Torre-Amione, G., Kapadia, S., Lee, J., et al. (1996) Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93, 704–711.PubMedGoogle Scholar
  5. 5.
    Iversen, P. O., Nicolaysen, G., and Sioud, M. (2001) DNA enzyme targeting TNF-alpha mRNA improves hemodynamic performance in rats with postinfarction heart failure. Am. J. Physiol. 281, H2211–H2217.Google Scholar
  6. 6.
    Woldbaek, P. R., Tonnessen, T., Henriksen, U. L., et al. (2003) Increased cardiac IL-18 mRNA, pro-IL-18 and plasma IL-18 after myocardial infarction in the mouse: a potential role in cardiac dysfunction. Cardiovasc. Res. 59, 122–131.CrossRefPubMedGoogle Scholar
  7. 7.
    Bohm, J. (2000) Gelatinous transformation of the bone marrow: the spectrum of underlying diseases. Am. J. Surg. Pathol. 24, 56–65.CrossRefPubMedGoogle Scholar
  8. 8.
    Ezekowitz, J. A., McAlister, F. A., and Armstrong, P. W. (2003) Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 107, 223–225.CrossRefPubMedGoogle Scholar
  9. 9.
    Mozaffarian, D., Nye, R., and Levy, W. C. (2003) Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). J. Am. Coll. Cardiol. 41, 1933–1939.CrossRefPubMedGoogle Scholar
  10. 10.
    Kalra, P. R., Collier, T., Cowie, M. R., et al. (2003) Haemoglobin concentration and prognosis in new cases of heart failure. Lancet 362, 211–212.CrossRefPubMedGoogle Scholar
  11. 11.
    Iversen, P. O., Woldbaek, P. R., Tonnessen, T., and Christensen, G. (2002) Decreased hematopoiesis in bone marrow of mice with congestive heart failure. Am. J. Physiol. 282, R166–R172.Google Scholar
  12. 12.
    Iversen, P. O., Woldbaek, P. R., and Christensen, G. (2005) Reduced immune responses to an aseptic inflammation in mice with congestive heart failure. Eur. J. Haematol. 75, 156–163.CrossRefPubMedGoogle Scholar
  13. 13.
    Rehbinder, C., Baneux, P., Forbes, D., et al. (1996) FELASA recommendations for the health monitoring of mouse, rat, hamster, gerbil, guinea pig and rabbit experimental units. Lab. Anim. 30, 193–208.CrossRefPubMedGoogle Scholar
  14. 14.
    Mahabir, E., Jacobsen, K., Brielmeier, M., Peters, D., Needham, J., and Schmidt, J. (2004) Mouse antibody production test: can we do without it? J. Virol. Methods 120, 239–245.CrossRefPubMedGoogle Scholar
  15. 15.
    Finsen, A. V., Christensen, G., and Sjaastad, I. (2005) Echocardiographic parameters discriminating myocardial infarction with pulmonary congestion from myocardial infarction without congestion in the mouse. J. Appl. Physiol. 98, 680–689.CrossRefPubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2007

Authors and Affiliations

  • Per Ole Iversen
    • 1
  • Dag R. Sørensen
    • 2
  1. 1.Department of Nutrition, Institute of Basic Medical SciencesUniversity of OsloOsloNorway
  2. 2.Centre of Comparative MedicineRikshospitalet University HospitalOsloNorway

Personalised recommendations